P4HA3
Basic information
Region (hg38): 11:74235801-74311640
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the P4HA3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 30 | 31 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 3 | |||||
Total | 0 | 0 | 33 | 1 | 0 |
Variants in P4HA3
This is a list of pathogenic ClinVar variants found in the P4HA3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
11-74235947-A-G | not specified | Uncertain significance (Jan 17, 2024) | ||
11-74239225-T-C | not specified | Uncertain significance (Feb 23, 2023) | ||
11-74239239-A-C | not specified | Uncertain significance (Jun 28, 2023) | ||
11-74246081-G-C | not specified | Uncertain significance (Dec 27, 2023) | ||
11-74246161-A-G | not specified | Uncertain significance (Nov 09, 2021) | ||
11-74251664-C-G | not specified | Uncertain significance (Apr 07, 2023) | ||
11-74253493-G-A | not specified | Uncertain significance (Dec 01, 2022) | ||
11-74253499-C-T | not specified | Uncertain significance (Jan 27, 2022) | ||
11-74267300-T-C | not specified | Uncertain significance (Oct 14, 2021) | ||
11-74268168-G-C | not specified | Uncertain significance (Apr 19, 2023) | ||
11-74268193-T-C | not specified | Likely benign (Mar 29, 2024) | ||
11-74268196-C-G | Likely benign (Sep 01, 2022) | |||
11-74268207-C-T | not specified | Uncertain significance (Jul 14, 2024) | ||
11-74269669-T-A | not specified | Uncertain significance (Jul 31, 2024) | ||
11-74269689-G-A | not specified | Uncertain significance (May 20, 2024) | ||
11-74277002-G-T | not specified | Uncertain significance (Sep 27, 2024) | ||
11-74279434-C-T | not specified | Uncertain significance (Jul 25, 2023) | ||
11-74285811-A-G | not specified | Uncertain significance (Oct 25, 2023) | ||
11-74285820-C-A | not specified | Uncertain significance (Oct 06, 2022) | ||
11-74285856-C-T | not specified | Uncertain significance (Aug 14, 2024) | ||
11-74285870-A-C | not specified | Uncertain significance (Feb 22, 2023) | ||
11-74285936-G-T | not specified | Uncertain significance (Aug 13, 2021) | ||
11-74285948-T-C | not specified | Uncertain significance (Dec 15, 2023) | ||
11-74285954-C-T | not specified | Uncertain significance (Jul 25, 2023) | ||
11-74285985-G-A | not specified | Uncertain significance (Jul 07, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
P4HA3 | protein_coding | protein_coding | ENST00000331597 | 13 | 75857 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
7.80e-10 | 0.888 | 125689 | 0 | 57 | 125746 | 0.000227 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.527 | 268 | 293 | 0.913 | 0.0000153 | 3464 |
Missense in Polyphen | 81 | 90.313 | 0.89688 | 1070 | ||
Synonymous | 0.968 | 104 | 117 | 0.886 | 0.00000611 | 1108 |
Loss of Function | 1.80 | 19 | 29.6 | 0.643 | 0.00000159 | 326 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000648 | 0.000648 |
Ashkenazi Jewish | 0.000101 | 0.0000992 |
East Asian | 0.000761 | 0.000761 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000133 | 0.000132 |
Middle Eastern | 0.000761 | 0.000761 |
South Asian | 0.000261 | 0.000261 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Catalyzes the post-translational formation of 4- hydroxyproline in -Xaa-Pro-Gly- sequences in collagens and other proteins. {ECO:0000269|PubMed:12874193, ECO:0000269|PubMed:14500733}.;
- Pathway
- Arginine and proline metabolism - Homo sapiens (human);Hyperornithinemia with gyrate atrophy (HOGA);Creatine deficiency, guanidinoacetate methyltransferase deficiency;L-arginine:glycine amidinotransferase deficiency;Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome];Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency);Prolinemia Type II;Prolidase Deficiency (PD);Arginine and Proline Metabolism;Hyperprolinemia Type I;Hyperprolinemia Type II;Ornithine Aminotransferase Deficiency (OAT Deficiency);Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency);Collagen biosynthesis and modifying enzymes;Collagen formation;Extracellular matrix organization;Urea cycle and metabolism of arginine, proline, glutamate, aspartate and asparagine
(Consensus)
Recessive Scores
- pRec
- 0.113
Intolerance Scores
- loftool
- 0.821
- rvis_EVS
- 0.07
- rvis_percentile_EVS
- 58.96
Haploinsufficiency Scores
- pHI
- 0.0625
- hipred
- N
- hipred_score
- 0.251
- ghis
- 0.476
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.965
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | High |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- P4ha3
- Phenotype
Gene ontology
- Biological process
- peptidyl-proline hydroxylation to 4-hydroxy-L-proline;oxidation-reduction process
- Cellular component
- endoplasmic reticulum;endoplasmic reticulum lumen
- Molecular function
- procollagen-proline 4-dioxygenase activity;iron ion binding;protein binding;oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen;L-ascorbic acid binding